Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Time and Personnel Costs Associated with Adverse Event (AE) Management Among Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Acalabrutinib, Ibrutinib, or Venetoclax

Hetalkumari Patel, Svea K. Wahlstrom, Maral DerSarkissian, Colin Kunzweiler, Felicia Castriota, Rose Chang, Hoi Ching Cheung, Yuqian Gu, Helen Guo, Mei Sheng Duh, Kellie J. Ryan

Blood (2021) 138 (Supplement 1): 2999.

https://doi.org/10.1182/blood-2021-147449

Published: 2021

Journal Articles

Real-World Ravulizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population

Wendy Y. Cheng, Jesse Fishman, Sujata P. Sarda, Sangeeta Krishnan, Colin Kunzweiler, Jensen Duy Vu, Mihran Yenikomshian, Mei Sheng Duh

Blood (2021) 138 (Supplement 1): 4999.

https://doi.org/10.1182/blood-2021-153106

Published: 2021

Journal Articles

Real-World Eculizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population

Wendy Y Cheng, PhD MPH, Sujata P. Sarda, PhD, Nikita Mody-Patel, PharmD, MBA, Sangeeta Krishnan, PharmD, MS, Mihran Yenikomshian, MBA, Patrick J. Scoble, PharmD, Colin Kunzweiler, PhD MS, Jensen Duy Vu, BA, Hoi Ching Cheung, BA, Mei Sheng Duh, ScD, MPH

Blood (2020) 136 (Supplement 1): 13.

https://doi.org/10.1182/blood-2020-141636

Published: 2020

Journal Articles

Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria Previously Treated with Eculizumab: A Matching-Adjusted Indirect Comparison

Rachel Y Bhak, MS, Nikita Mody-Patel, PharmD, MBA, Scott B. Baver, PhD, Colin Kunzweiler, PhD MS, Christopher Yee, ScM, Sanjana Sundaresan, ScM, Natalia Swartz, MPH, Mei Sheng Duh, ScD, MPH, Sangeeta Krishnan, PharmD, MS, Sujata P. Sarda, PhD

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-141667

Published: 2020